BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5169924)

  • 21. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
    Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
    Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lampren in the treatment of leprosy].
    Ahrens T
    Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute abdomen in a patient treated with lamprene.
    Jagadeesan K; Visweswaran MK; Iyer KH
    Int Surg; 1975 Apr; 60(4):208-9. PubMed ID: 1091577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A field trial among leprosy patients in Nigeria with depot injections of dapsone and monoacetyldapsone.
    Pieters FA; Woonink F; Zuidema J
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):10-20. PubMed ID: 3373080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter: Use of drugs and their effects on leprosy patients.
    Graver V
    Int J Lepr Other Mycobact Dis; 1974; 42(1):72. PubMed ID: 4472185
    [No Abstract]   [Full Text] [Related]  

  • 26. New drug for leprosy.
    Br Med J; 1969 Mar; 1(5647):797-8. PubMed ID: 5774074
    [No Abstract]   [Full Text] [Related]  

  • 27. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report.
    Devadason C
    Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239
    [No Abstract]   [Full Text] [Related]  

  • 28. [Early diagnosis, therapy, and research in the control of leprosy].
    Contreras Duenas F
    Offentl Gesundheitswes; 1970 Dec; 32(12):667-71. PubMed ID: 4250373
    [No Abstract]   [Full Text] [Related]  

  • 29. Histochemistry of B663 pigmentation: ceroid-like pigmentation in macrophages.
    Sakurai I; Skinsnes OK
    Int J Lepr Other Mycobact Dis; 1977; 45(4):343-54. PubMed ID: 75860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy of leprosy.
    Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; Martínez Domínguez V
    Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Activity of B663 in lepromatous leprosy. Therapeutic trial].
    Pene P; Carrie J; Bourgeade A; Bolliot Y
    Bull Soc Pathol Exot Filiales; 1971; 64(4):407-15. PubMed ID: 5172361
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 33. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dapsone-induced photodermatitis in a patient with leprosy].
    Fumey SM
    Z Hautkr; 1988 Jan; 63(1):53-4. PubMed ID: 3354248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A report on a controlled clinical trial with conventional and one third conventional dose of dapsone administered orally once a week in lepromatous patients.
    Ramanujam K; Iyer CG; Ramu G
    Lepr Rev; 1975 Jun; 46(2 Suppl):93-7. PubMed ID: 1100971
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemical drug delivery systems: I. Preparation and evaluation of prodrugs of dapsone.
    Kulkarni VM; Mishra DS
    Indian J Lepr; 1985; 57(4):756-62. PubMed ID: 3835207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of leprosy.
    Ramanujam K
    J Indian Med Assoc; 1973 Nov; 61(9):401-2. PubMed ID: 4791935
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental studies in man on hyaluronidase inhibiting effect of clofazimine].
    Mathies H; Ress U
    Arzneimittelforschung; 1970 Dec; 20(12):1838-40. PubMed ID: 5537076
    [No Abstract]   [Full Text] [Related]  

  • 39. The treatment of erythema nodosum leprosum with B.663. A controlled study.
    Pettit JH
    Int J Lepr Other Mycobact Dis; 1967; 35(1):11-6. PubMed ID: 4290017
    [No Abstract]   [Full Text] [Related]  

  • 40. Fluorimetric screening of dapsone in urine for drug trials.
    Balakrishnan S
    Lepr India; 1980 Apr; 52(2):245-8. PubMed ID: 7005540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.